Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative inspired oxygen fraction and dexmedetomidine for postoperative pulmonary complications in frail patients undergoing major abdominal surgery
ChiCTR2500096839Phase 4Not yet recruiting
- Sponsor
- The Fourth Hospital of Hebei Medical University
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in postoperative respiratory complications (PRC) (4 arms), sponsored by The Fourth Hospital of Hebei Medical University. Primary endpoint: Incidence of pulmonary complications within 7 days after surgery. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative respiratory complications (PRC)
Beyond the preview
Go deeper on ChiCTR2500096839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096839.